01 8Xeloda
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 418
2018 Revenue in Millions : 440
Growth (%) : -5
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 335
2019 Revenue in Millions : 452
Growth (%) : -26
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 209
2020 Revenue in Millions : 319
Growth (%) : -36
Main Therapeutic Indication : Oncology
Currency : USD
2014 Revenue in Millions : -48.60%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Oncology
Currency : USD
2015 Revenue in Millions : 784
2014 Revenue in Millions : 518
Growth (%) : -34%
Main Therapeutic Indication : Oncology
Currency : USD
2016 Revenue in Millions : 501
2015 Revenue in Millions : 508
Growth (%) : -1
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 480
2016 Revenue in Millions : 536
Growth (%) : -10
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 431
2017 Revenue in Millions : 458
Growth (%) : -6%
LOOKING FOR A SUPPLIER?